Uncovering growth-Suppressive micro rNAs in lung cancer

Clinical Cancer Research

Volumn 15, Issue 4, 2009, Pages 1177-1183

  Liu, X ^a   Sempere, L F ^a   Galimberti, F ^a   Freemantle, S J ^a   Black, C ^a   Dragnev, K H ^a   Yan, M ^a   Fiering, S ^a   Memoli, V ^a   Li, H ^a   Direnzo, J ^a   Korc, M ^a   Cole, C N ^a   Bak, M ^b,c   Kauppinen, S ^b,c,d   Dmitrovsky, E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Santaris Pharma AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; MICRORNA; MICRORNA 142 5P; MICRORNA 145; MICRORNA 34C; PROTEASOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE OVEREXPRESSION; IN SITU HYBRIDIZATION; LUNG CANCER; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 63149123608     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1355     Document Type: Article

References (29)

1. Garzon R, Fabbri M, Cimmino A, Calin GA. Croce CM. MicroRNA expression and function in cancer. Trends Mol Med 2006;12:580-7.
2. Zeng Y. Principles of micro-RNA production and maturation. Oncogene 2006;25:6156-62.
3. Valencia-Sanchez MA, Liu J, Hannon GJ, and Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20:515-24.
4. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006:6:259-69.
5. Jay C, Nemunaitis J, Chen P, Fulgham P, Tong AW. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol 2007;26:293-300.
6. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2002;52:23-47.
7. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98.
8. He L. Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435:828-33.
9. Chang T-C,Yu D, Lee Y-S, et al. Widespread microRNA repression by myc contributes to tumorigenesis. Nat Genet 2008;40:43-50.
10. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007;67:8433-8.
11. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apopto- sis in neuroblastoma cells. Oncogene 2007;26:5017 - 22.
12. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescencelike growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 2007;104:15472-7.
13. BommerGT, Gerin I, FengY, etal. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007;17:1298 - 307.
14. Ma Y, Fiering S, Black C, et al. Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A 2007;104: 4089-94.
15. Cole K,TruongV, Barone D, McGall G. Direct labeling of RNA with multiple biotins allows sensitive expression profiling of acute leukemia class predictor genes. Nucleic Acids Res 2004;32:e86.
16. Wienholds E, Kloosterman WP, Miska E, et al. MicroRNA expression in zebrafish embryonic development. Science 2005;309:310-1.
17. Petty WJ, Li N, Biddle A, et al. A novel retinoic acid receptor β isoform and retinoid resistance in lung carcinogenesis. J Natl Cancer Inst 2005;97:1645-51.
18. Huber w, von Heydebreck A, Sultmann H, Poustka A, Vingron M. variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002; 18:S96-104.
19. Saeed Al, Sharov V. White J, et al. TM4: a free, open- source system for microarray data management and analysis. Biotechniques 2003;34:374-8.
20. Sempere LF, Christensen M, Silahtaroglu A, et al. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 2007;67:11612-20.
21. DiRenzo J, Signoretti S, Nakamura N, et al. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res 2002; 62:89-98.
22. Langenfeld J, Kiyokawa H, Sekula D, Boyle J, Dmitrovsky E. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc Natl Acad Sci U S A 1997;94:12070-4.
23. Michael MZ, O' Connor SM, van Hoist Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91.
24. lorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-70.
25. Diederichs S, Haber DA. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res 2006;66:6097-104.
26. Krek A, Griln D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37: 495-500.
27. Lewis BP, Shih l-H, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003;115:787-98.
28. Elmen J, Lindow M, Silahtaroglu A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimi R leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008;36:1153-62.
29. Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin Cancer Biol 2008;18:89-102.